Chargement en cours...
Anti-tumor immune response in early stage non small cell lung cancer (NSCLC): implications for adjuvant therapy
The demonstration that systemic chemotherapy improves survival in patients who have had resection of early stage non-small cell lung cancer (NSCLC) represents a significant advance. The absolute benefit of adjuvant chemotherapy in this setting is small with an overall survival improvement of 5%. In...
Enregistré dans:
| Publié dans: | Transl Lung Cancer Res |
|---|---|
| Auteur principal: | |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Pioneer Bioscience Publishing Company
2013
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4367725/ https://ncbi.nlm.nih.gov/pubmed/25806261 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.2218-6751.2013.10.09 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|